Prostacycline analogue inhibiting platelet reactions .Used in severe chronic peripheral circulatory insufficiency with impending risk for amputation Administered as infusion 0.5-2.0 ng/kg BW/ min. Metabolized by beta-oxidation.
Similar drugs
Explore alternative drugs in similar therapeutic classes
B01A /
B01AC or
go back.